Focus is the online newsletter for Norris Cotton Cancer Center.
News is posted as it happens, making Focus the most up-to-date source of information about the developments and people at the Cancer Center.
The Latest in Focus
Fighting ER+ Breast Cancer
ER+ breast cancer is especially difficult to treat because it develops a resistance to the anti-estrogen drugs usually used in treatment. A new NCCC clinical trial will test lab research that shows estrogen can induce and inhibit tumor growth.
Articles can be browsed by the following categories:
Subscribe to the Focus Newsletter
Receive Focus Newsletter articles in your Inbox or via RSS Feed.